New hope for Men's UTIs: safer antibiotic could replace risky standard care

NCT ID NCT06822751

First seen Feb 18, 2026 · Last updated May 14, 2026 · Updated 13 times

Summary

This study tests whether a common antibiotic for women's UTIs (fosfomycin-trometamol) works well for men with urinary tract infections. Current treatments can cause rare but serious side effects. The trial will enroll 138 men in primary care and track treatment success for 14 days after therapy ends.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for URINARY TRACT INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.